共 68 条
[1]
Straw S(2021)Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction Open Heart 325 293-302
[2]
McGinlay M(1991)Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 371 993-1004
[3]
Witte KK(2014)Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 353 9-13
[4]
Investigators S(1999)The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 364 11-21
[5]
McMurray JJ(2011)Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 382 972-3726
[6]
Zannad F(2020)Dapagliflozin in patients with heart failure and reduced ejection fraction N Engl J Med 42 3599-270
[7]
Borghi C(2021)ESC guidelines for the diagnosis and treatment of acute and chronic heart failure Eur Heart J 16 233-142
[8]
Cicero AFG(2015)Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Eur Heart J Cardiovasc Imaging 41 136-380
[9]
McDonagh TA(2018)Mortality reduction associated with beta-adrenoceptor inhibition in chronic heart failure is greater in patients with diabetes Diabetes Care 23 352-224
[10]
Metra M(2021)Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association Eur J Heart Fail 5 218-2486